Colorectal cancer is characterized by a significant increase in key areas, including: (i) cancer growth markers, specifically PCNA; (ii) cancer metastasis biomarkers, such as MMP-9 level; (iii) inflammation markers, like IL-6; and (iv) DNA fragmentation as an apoptotic biomarker. Here, PCNA is linked to colorectal cancer.